What DIAVERUM Portugal does

Diaverum Portugal is the Portuguese operating subsidiary of Diaverum, a global renal care provider founded in Sweden in 1991 (originally as Gambro Healthcare) and now owned by health-technology platform M42 (Mubadala/G42 origin). The company runs 28 dialysis clinics across Portugal — 12 in the North, 5 in the Centre, and 11 in the Lisbon and Vale do Tejo region — staffed by more than 1,500 healthcare professionals and serving approximately 3,500 chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients. Its service portfolio spans haemodialysis, nocturnal dialysis, home and autonomous/shared haemodialysis, kidney transplant support, and the d.HOLIDAY international travel-dialysis programme coordinated with bookdialysis.com.

Underlying the clinical operation is a proprietary digital ecosystem: d.CARE as the renal information management system, TGS as a tablet-based treatment-guidance workflow tool for nurses, d.CONNECT for automated ingestion of dialysis-monitor and scale data, and d.ACADEMY for virtual education. In 2026 Diaverum and M42 launched the kidney.com AI conversational assistant in Portugal, with voice, multilingual (including Portuguese), and label-interpretation capabilities. AI initiatives also include the AV.AI vascular-access thrombosis model and bioimpedance-based hydration analytics presented at the 63rd ERA Congress. The company holds ISO 9001 and ISO 14001 certifications, with published intradialytic-nutrition research in Clinical Nutrition (IF 7.9).

Diaverum Portugal's revenue is generated primarily through contracted dialysis services with the Portuguese National Health Service (SNS), supplemented by private-insurer arrangements and out-of-pocket revenue from the d.HOLIDAY programme. Patients are acquired largely via SNS referrals and clinic-network proximity, with international demand captured through d.HOLIDAY marketing, the bookdialysis.com self-serve channel, and partnerships with patient associations such as APIR and travel operators including True Traveller. The entity is privately held under M42 and operates with locally appointed leadership (General Director Sofia Correia de Barros, appointed 2020; National Medical Director Dr. Rui Filipe, appointed 2025).

Name

DIAVERUM Portugal

Legal name

Diaverum

Website

https://diaverum.pt

Company type

Private

Founded year

1991

Operating status

Operating

Short description

Diaverum Portugal operates 28 dialysis clinics across Portugal, serving approximately 3,500 chronic kidney disease patients with over 1,500 professionals as the Portuguese subsidiary of M42-owned Diaverum. It delivers haemodialysis, nocturnal dialysis, transplant support, and holiday dialysis via its d.CARE digital platform.

Ownership category

akta.pro rank

Product category

Renal Care / Dialysis Services

NAICS

Kidney Dialysis Centers (621492)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

akta.pro secondary industry

Nephrology Telemedicine Platforms (HLALAGAI)

Keywords

• Dialysis services
• Renal care
• Haemodialysis clinics
• Nephrology services
• Kidney treatment

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Dialysis Treatment Services: Diaverum Portugal generates revenue by providing dialysis and renal care services to patients across 28 clinics in Portugal. Revenue comes from contracted arrangements with national health system payers and potentially private insurers, covering haemodialysis, nocturnal dialysis, and related treatment services. The company also offers holiday dialysis (d.HOLIDAY) to international patients as a revenue stream.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

DIAVERUM Portugal operates a network of 28 dialysis clinics delivering haemodialysis (including nocturnal, home, and autonomous/shared modalities), kidney transplant support, and interdisciplinary care (medical, nutritional, psychosocial, and pharmaceutical) to approximately 3,500 chronic kidney disease patients across Portugal. Its d.HOLIDAY programme provides holiday dialysis for international travellers, and the Fly Back programme supports transplant recall logistics. Care delivery is supported by proprietary digital platforms — d.CARE, Treatment Guidance System (TGS), d.CONNECT, d.ACADEMY, and the kidney.com AI assistant.

Product overview

Diaverum Portugal operates as a dialysis care provider with a digital product ecosystem centered on the d.CARE renal information management platform, supported by the TGS (Treatment Guidance System), d.CONNECT automated data collection, d.ACADEMY education platform, and the d.CARE mobile application. The kidney.com AI assistant provides conversational renal health education. The d.HOLIDAY program facilitates international dialysis travel. All services are delivered across 28 Diaverum clinics in Portugal, supported by multidisciplinary teams including medical, nursing, nutritional, social, and pharmaceutical professionals.

Differentiator

Problem solved

Functional benefit

Brands

• d.HOLIDAY: Dialysis holiday program enabling renal patients to travel and receive treatment at Diaverum clinics worldwide
• d.CARE
• d.ACADEMY
• TGS (Treatment Guidance System)
• d.CONNECT
• kidney.com

Products and services

• Haemodialysis Treatment
• Nocturnal Haemodialysis (Diálise Noturna) Overnight haemodialysis programme that lets patients dialyse while they sleep, freeing daytime hours for work, family, and social activities. Designed to improve quality of life and clinical outcomes for suitable CKD/ESRD patients.
• d.HOLIDAY Holiday Dialysis Programme International holiday dialysis programme enabling renal patients to travel to Portugal and receive treatment at any of the 28 Diaverum clinics. Includes welcome packages with hotel/restaurant partnerships across 12 cities, destination coordination by Marta Olim, and group travel via the 'Vamos Viajar Juntos' initiative.
• Fly Back Transplant Support Programme Coordination programme that arranges the rapid return of a dialysis patient to their home clinic when they receive a transplant call while travelling. Removes a major barrier to travel for transplant-eligible patients.
• Nutritional Support Service (Nutrição) Personalised dietary support and nutritional counselling for dialysis patients, integrated into every clinic's interdisciplinary care model. Includes Diaverum Portugal's signature intradialytic nutrition programme, whose outcomes were published in Clinical Nutrition (IF 7.9).
• Psychosocial Support Service (Serviço Social) Social-worker-led psychosocial support for dialysis patients and their families, addressing emotional, social, and financial stressors of living with chronic kidney disease.
• Pharmaceutical Service (Farmácia) Pharmacy service supporting therapeutic adherence and medication management for dialysis patients, coordinated centrally and delivered across all Diaverum Portugal clinics.
• kidney.com AI Renal Health Assistant

Quantifiable outcome

• 97% of patients without contraindications choose to eat a snack during haemodialysis treatment, demonstrating high acceptance of the intradialytic nutrition programme
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• M42 (Mubadala Health and G42)coreOthers · 1 January 2026M42 is the parent company of Diaverum, having acquired the company as part of its global health technology portfolio. M42 combines clinical expertise with AI and data capabilities to reinvent healthcare. The kidney.com AI platform launch in Portugal is a joint initiative between Diaverum and M42, reflecting M42's commitment to building next-generation AI-driven health systems.
• NOVA Medical SchoolcoreStrategic or Co-development Partner · 1 January 2025Diaverum Portugal partnered with NOVA Medical School to develop the MedCook Book, a recipe book tailored for chronic kidney disease patients. This collaboration combines clinical nutritional expertise from both organisations to produce patient education materials that are both scientifically grounded and practically useful. The book was launched under the title 'Saúde à Mesa. Nutrição adaptada a doentes renais crónicos.'
• APIR (Associação de Doentes Renais de Portugal)coreStrategic or Co-development Partner · 1 January 2023APIR partnered with Diaverum Portugal and True Traveller to create the 'Vamos Viajar Juntos' programme, enabling groups of dialysis patients and their families to travel together. The first edition took place in Amarante in May 2023, with subsequent editions in Águeda (2024) and the Central Region (2025). This programme embodies Diaverum's social responsibility culture of 'True Care'.
• True TravellercoreStrategic or Co-development Partner · 1 January 2023True Traveller collaborated with Diaverum Portugal and APIR to develop and deliver the 'Vamos Viajar Juntos' travel programme for dialysis patients. The programme enables groups to travel together with dialysis treatment provided at local Diaverum clinics.

Scale indicators8 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Fresenius Medical Care: Global leader in dialysis products and services, operating the largest network of dialysis clinics worldwide and a direct competitor to Diaverum Portugal in the Portuguese outpatient dialysis market.
• Nipro Corporation: Global medical device and dialysis company with both equipment manufacturing and dialysis services operations. Broad incumbent in the renal care value chain that competes with Diaverum on consumables and integrated services.

Direct peers

• DaVita: Major US-headquartered dialysis services provider with growing international presence, operating outpatient dialysis clinics in multiple countries including Portugal; directly competes with Diaverum Portugal for NHS contracts and patients.
• Diaverum (Global Parent): Global parent operating 460+ dialysis clinics across 25 countries, providing the digital platform (d.CARE, TGS), centralized R&D, and strategic direction that Diaverum Portugal leverages. Benchmarks unit economics and operating model across the network.
• B. Braun Avitum: European dialysis services arm of B. Braun, operating outpatient dialysis centers across Europe. Direct competitor in the European outpatient dialysis market with similar interdisciplinary care model.

Emerging players

• U.S. Renal Care: Mid-sized US dialysis services provider focused on outpatient and home dialysis. Comparable in scale and clinic-network model to Diaverum Portugal, though primarily US-focused.

Regional players

• Diaverum Spain: Diaverum's Spanish subsidiary operating dialysis clinics in Spain, an immediate Iberian peer sharing the same digital platform, clinical protocols, and parent backing as Diaverum Portugal.

Others

• Lusíadas Saúde: Major Portuguese private healthcare provider with hospitals and outpatient services. Indirect competitor/referral partner for dialysis patients in Portugal's broader healthcare ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIAVERUM Portugal